Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08SSP
|
||||
Former ID |
DNCL002997
|
||||
Drug Name |
Lersivirine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] | Phase 2 | [523279] | ||
Company |
ViiV Healthcare
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H19N4O2+
|
||||
Canonical SMILES |
CCC1=C(C(=NN1CCO)CC)OC2=CC(=CC(=C2)[N+]#C)C#N
|
||||
InChI |
1S/C17H19N4O2/c1-4-15-17(16(5-2)21(20-15)6-7-22)23-14-9-12(11-18)8-13(10-14)19-3/h3,8-10,22H,4-7H2,1-2H3/q+1
|
||||
InChIKey |
FDKFFEDNWJEELJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | HIV reverse transcriptase | Target Info | Inhibitor | [531272] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.